Legrand, N.; Pradier, A.; Poulain, L.; Mouche, S.; Birsen, R.; Larrue, C.; Simonetta, F.; Tamburini, J.
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia. Cancers 2021, 13, 5966.
https://doi.org/10.3390/cancers13235966
AMA Style
Legrand N, Pradier A, Poulain L, Mouche S, Birsen R, Larrue C, Simonetta F, Tamburini J.
AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia. Cancers. 2021; 13(23):5966.
https://doi.org/10.3390/cancers13235966
Chicago/Turabian Style
Legrand, Noémie, Amandine Pradier, Laury Poulain, Sarah Mouche, Rudy Birsen, Clément Larrue, Federico Simonetta, and Jerome Tamburini.
2021. "AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia" Cancers 13, no. 23: 5966.
https://doi.org/10.3390/cancers13235966
APA Style
Legrand, N., Pradier, A., Poulain, L., Mouche, S., Birsen, R., Larrue, C., Simonetta, F., & Tamburini, J.
(2021). AMP-Activated Protein Kinase Contributes to Apoptosis Induced by the Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia. Cancers, 13(23), 5966.
https://doi.org/10.3390/cancers13235966